Anhui Model Suggests More Pricing Pressure From Chinese Drug Tenders
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Meetings with government officials involved with the tender process in China's Anhui province suggest that the impact of price cuts for essential drugs has been greater than expected, Morgan Stanley analysts say in a June 6 research report